Investors
Press releases
-
Non Regulatory September 9, 2021Nanoform technology delivers successful results for Herantis CDNF drug candidate
-
Regulatory August 27, 2021The Board of Directors of Nanoform Finland Plc decided on issue of stock options to key employees
-
Regulatory August 26, 2021Nanoform Interim Report January – June 2021
Nanoform Finland Plc (“Nanoform”), published its Q2/2021 report on August 26, 2021, at 8.10 a.m. Finnish time / 7.10 a.m. Swedish time. The company will hold a conference call and an online presentation on the same day at 3.00 p.m. Finnish time / 2.00 p.m. Swedish time.